Gonadotrophin releasing hormone agonist (GnRHa)-Zoladex (Goserelin) and hormonal add-back therapy in endometriosis: a 12 month study

P.I. Lee, J.B. Yoon, Kyeong-Jin Joo, J.K. Lee, J.Y. Cho, J.S. Kim
In: Fertility and Sterility · 2002 · vol. 77 , pp. S23 · doi:10.1016/s0015-0282(01)03083-7 · W2037858676
article OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-07, 2026-07-18 ⓘ

This 12-month study investigated the effects of Goserelin (a GnRHa agonist) with hormonal add-back therapy in endometriosis patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK